JAMA Netw Open 7(8):e2423385 [DOI] [PMC free article] [PubMed] [Google Scholar] 85.Zhou J, Huang W, Xie Y, Shen H, Liu M, Wu X (2025) Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database
Ginseng may potentially stimulate GLP-1 secretion
The rationale for and results of these studies are discussed in the present review
The analysis showed that metabolic surgery significantly reduced major adverse cardiovascular events over 3.9 years of follow-up, with a hazard ratio of 0.61
Natural limits of pregnancy testing in relation to the expected menstrual period
Novo Nordisk also took legal action against Hims & Hers, alleging that the telehealth provider was unlawfully mass marketing unapproved versions of Novo Nordisks FDA-approved semaglutide medicines (Wegovy and Ozempic)